ABSTRACT
ICU patients, mainly those who need prolonged ventilatory support, may require tracheostomy, which once was done in the operating room, nowadays is performed in the ICU, as percutaneous dilatational tracheostomy [PDT]. Forty two patients 18-72 yrs of age [mean 44 yrs], with varying indications for tracheostomy, had undergone PDT in the ICU under the standard protocol for this procedure. The mean time for completion of the procedure was 10 min. Advantages and complications are reviewed. The difficulties encountered were mainly the anatomical landmarks [10%], difficulties in dilatation [5%] and peristomal oozimg [1%]. It is concluded that percutaneous dilatational tracheostomy is an easy, cost effective, practical when done at bedside in the ICU, and spares transferring the patient to the operating theater
Subject(s)
Humans , Male , Female , Point-of-Care Systems , Surgical Instruments , Tracheostomy/instrumentationABSTRACT
Nine cases of malignant hyperthermia occured at King Hussein Medical Centre [KHMC] between 1971 and 1983. There were 78% male and 22% female patients.The incidence among young children was high in our series 44%. Overall mortality rate within two weeks of the episode was 44%. This is a review of our experience and of the literature. Malignant hyperthermia [MH] is a rare condition in which genetically susceptible subjects exhibit an abnormal response to stress and anesthesia. The first report in Jordan was 1972[1]. The objective of this paper is to review our experience at KHMC with special reference to the role of verapamil Ca ++ channel blocker in [MH] management